<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-GOE23A57-TJ5-FT-MY7"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 S2456 IS: Protecting Seniors from High Drug Costs Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2023-07-20</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>118th CONGRESS</congress><session>1st Session</session><legis-num>S. 2456</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20230720">July 20, 2023</action-date><action-desc><sponsor name-id="S309">Mr. Casey</sponsor> (for himself and <cosponsor name-id="S287">Mr. Cornyn</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSFI00">Committee on Finance</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To amend title XVIII of the Social Security Act to limit beneficiary cost-sharing to the net price of covered part D drugs.</official-title></form><legis-body><section id="S1" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Protecting Seniors from High Drug Costs Act</short-title></quote>.</text></section><section id="idf07ba3799f51451d971ef0fe497e70e1"><enum>2.</enum><header>Protecting seniors from excessive cost-sharing under Medicare part D</header><subsection id="id83c6ff9c485c4aa4b316765058a6756d"><enum>(a)</enum><header>In general</header><text>Section 1860D–2 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-102">42 U.S.C. 1395w–102</external-xref>) is amended—</text><paragraph id="id2892a21164c64d339a1c29cf7962cce4"><enum>(1)</enum><text>in subsection (b)—</text><subparagraph id="id3ce5a8aa234c4ed2b97b2ee900fbaa0d"><enum>(A)</enum><text>in paragraph (2)(A), in the matter preceding clause (i), by striking <quote>and (9)</quote> and inserting <quote>, (9), and (10)</quote>; and</text></subparagraph><subparagraph id="id17d568fa197b4f6bbd3c525e943cb772"><enum>(B)</enum><text>by adding at the end the following new paragraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="id024A267A53F84CD3B0D28C0A2E780EA8"><paragraph id="idcda5459b39344536a94b7776dfb8a065"><enum>(10)</enum><header>Limiting cost-sharing to net price</header><subparagraph id="ide9658b985ab943018caa9d1b140998b7"><enum>(A)</enum><header>In general</header><text>For plan years beginning on or after January 1, 2026, the cost-sharing (for costs above the annual deductible specified in paragraph (1)) for a covered part D drug (other than a covered part D drug described in paragraph (8) or (9)) shall not exceed the applicable amount specified in subparagraph (B).</text></subparagraph><subparagraph id="idea869239e28640958d015663911d66fd"><enum>(B)</enum><header>Applicable amount specified</header><text>The applicable amount specified in this subparagraph, with respect to a covered part D drug under a prescription drug plan or an MA–PD plan, is the negotiated price of the covered part D drug under the prescription drug plan or MA–PD plan, net of any manufacturer-provided price concessions (as defined under section 423.100 of title 42, Code of Federal Regulations (or any successor regulation)), as reported for such drug in the Detailed DIR Report (or any successor report) submitted by the sponsor or organization offering the plan for the previous plan year.</text></subparagraph><subparagraph id="id8875f2537b4548888b550ee0a56f1a16"><enum>(C)</enum><header>Enforcement</header><clause id="id13141227ae5f48b2ad52958fe6382efb"><enum>(i)</enum><header>In general</header><text>A PDP sponsor of a prescription drug plan or an MA organization offering an MA–PD plan that violates the requirements under this paragraph, with respect to a covered part D drug under such plan, may be subject to a civil monetary penalty, as determined appropriate by the Secretary.</text></clause><clause id="idb8e7b4f2d53b4dc78b456dbebc6350ce"><enum>(ii)</enum><header>Application</header><text>The provisions of section 1128A (other than subsections (a) and (b)) shall apply to a civil monetary penalty under this subparagraph in the same manner as such provisions apply to a penalty or proceeding under section 1128A(a).</text></clause></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="id66e80977696a4565a55a70c6e2a25430"><enum>(2)</enum><text>in subsection (c), by adding at the end the following new paragraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="id97422ED327554FF9B7747F7F19A51648"><paragraph id="id43acf573a8354ea4829dc72d7af03cc5"><enum>(7)</enum><header>Limiting cost-sharing to net price</header><text>The coverage is provided in accordance with subsection (b)(10).</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection id="id3a8846ef4c104dc8a9160938ead9d6ee"><enum>(b)</enum><header>Conforming amendment to cost-Sharing for low-Income individuals</header><text>Section 1860D–14(a)(1)(D)(iii) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-114">42 U.S.C. 1395w–114(a)(1)(D)(iii)</external-xref>) is amended by adding at the end the following new sentence: <quote>For plan year 2026, and subsequent plan years, the copayment amount applicable under this clause to a covered part D drug dispensed to the individual may not exceed the applicable amount specified in section 1860D–2(b)(10)(B) for the covered part D drug under the prescription drug plan or MA–PD plan in which the individual is enrolled.</quote>. </text></subsection></section></legis-body></bill> 

